PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
NCT03748706
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
13
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer Disease
Interventions
DRUG:
PTI-125, 100 mg tablets
Sponsor
Pain Therapeutics
Collaborators
[object Object]